160 related articles for article (PubMed ID: 7533663)
1. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
Vukanovic J; Isaacs JT
Cancer Res; 1995 Apr; 55(7):1499-504. PubMed ID: 7533663
[TBL] [Abstract][Full Text] [Related]
2. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.
Joseph IB; Isaacs JT
Prostate; 1996 Sep; 29(3):183-90. PubMed ID: 8827087
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
[TBL] [Abstract][Full Text] [Related]
4. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
Vukanovic J; Isaacs JT
Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
Joseph IB; Vukanovic J; Isaacs JT
Cancer Res; 1996 Aug; 56(15):3404-8. PubMed ID: 8758902
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
Vukanovic J; Passaniti A; Hirata T; Traystman RJ; Hartley-Asp B; Isaacs JT
Cancer Res; 1993 Apr; 53(8):1833-7. PubMed ID: 7682157
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.
Vukanovic J; Hartley-Asp B; Isaacs JT
Prostate; 1995 May; 26(5):235-46. PubMed ID: 7538663
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
Borgström P; Torres Filho IP; Hartley-Asp B
Anticancer Res; 1995; 15(3):719-28. PubMed ID: 7544090
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation.
Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
Immunol Lett; 2007 Dec; 114(2):81-5. PubMed ID: 17964662
[TBL] [Abstract][Full Text] [Related]
11. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents.
Joseph IB; Isaacs JT
J Natl Cancer Inst; 1998 Nov; 90(21):1648-53. PubMed ID: 9811314
[TBL] [Abstract][Full Text] [Related]
12. Multiformic modulation of endotoxin effects by linomide.
Shalev M; Ko A; Gelderman MP; Fortin E; Reed G; Slavin S; Gery I
Clin Immunol; 1999 Dec; 93(3):250-5. PubMed ID: 10600336
[TBL] [Abstract][Full Text] [Related]
13. Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.
Johnson CS; Pourbohloul SC; Furmanski P
Exp Hematol; 1991 Feb; 19(2):101-5. PubMed ID: 1991491
[TBL] [Abstract][Full Text] [Related]
14. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
Isaacs JT; Pili R; Qian DZ; Dalrymple SL; Garrison JB; Kyprianou N; Björk A; Olsson A; Leanderson T
Prostate; 2006 Dec; 66(16):1768-78. PubMed ID: 16955399
[TBL] [Abstract][Full Text] [Related]
15. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
16. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-alpha production in vitro.
Darville T; Tabor D; Simpson K; Jacobs RF
Pediatr Res; 1994 Apr; 35(4 Pt 1):397-403. PubMed ID: 8047375
[TBL] [Abstract][Full Text] [Related]
18. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
Hoffman M; Cooper ST
Blood Cells Mol Dis; 1995; 21(2):156-67. PubMed ID: 8846045
[TBL] [Abstract][Full Text] [Related]
19. Effect of alcohol on the secretion of tumor necrosis factor-alpha by macrophages in the presence of rat serum.
Nakatani Y; Fukui H; Kitazawa T; Fujimoto M; Yamao J; Uemura M
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):81S-85S. PubMed ID: 12198381
[TBL] [Abstract][Full Text] [Related]
20. Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia.
Huang WJ; Yeh JY; Kan SF; Chang LS; Wang PS
J Cell Biochem; 2003 Mar; 88(4):766-73. PubMed ID: 12577310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
